1 | taking | 8,722 |
2 | 'taking | 7 |
3 | 7-dependent | 5 |
4 | self-titrated | 5 |
5 | 6-dependent | 4 |
6 | co-dispensed | 4 |
7 | peptide-modified | 3 |
8 | re-started | 3 |
9 | -taking | 2 |
10 | hyperventilating | 2 |
11 | jinfukang | 2 |
12 | polymerising | 2 |
13 | very-high-dose | 2 |
14 | 0.07g/kg | 1 |
15 | 21/445 | 1 |
16 | 39m | 1 |
17 | accept/tolerate | 1 |
18 | adherence-as | 1 |
19 | antidepressant/neuroleptic | 1 |
20 | argulid | 1 |
21 | centralising | 1 |
22 | delving | 1 |
23 | dental/alveolar | 1 |
24 | elavated | 1 |
25 | factor-lowering | 1 |
26 | fast-the | 1 |
27 | giac | 1 |
28 | higher-dosed | 1 |
29 | hufnagel | 1 |
30 | individuals.as | 1 |
31 | intra-appointment | 1 |
32 | isorhamnetin- | 1 |
33 | management/pill | 1 |
34 | n-hydroxyl | 1 |
35 | nitrendipine-based | 1 |
36 | non-anesthetic | 1 |
37 | nonvasodilatory | 1 |
38 | o-formyl | 1 |
39 | omnii | 1 |
40 | other-type | 1 |
41 | outlicensing | 1 |
42 | peanuts/tree | 1 |
43 | pentamethylcyclopentadienyl | 1 |
44 | provided.single-chamber | 1 |
45 | raas-directed | 1 |
46 | rare.with | 1 |
47 | reported.zinc | 1 |
48 | requiringurinary | 1 |
49 | respondersto | 1 |
50 | service-connection | 1 |
51 | st/mi | 1 |
52 | standardized-one | 1 |
53 | sustained.when | 1 |
54 | td49-encapsidated | 1 |
55 | university-student | 1 |
56 | vigilance-stabilising | 1 |
1 | 'taking | 7 |
2 | -taking | 2 |
3 | 0.07g/kg | 1 |
4 | 21/445 | 1 |
5 | 39m | 1 |
6 | 6-dependent | 4 |
7 | 7-dependent | 5 |
8 | accept/tolerate | 1 |
9 | adherence-as | 1 |
10 | antidepressant/neuroleptic | 1 |
11 | argulid | 1 |
12 | centralising | 1 |
13 | co-dispensed | 4 |
14 | delving | 1 |
15 | dental/alveolar | 1 |
16 | elavated | 1 |
17 | factor-lowering | 1 |
18 | fast-the | 1 |
19 | giac | 1 |
20 | higher-dosed | 1 |
21 | hufnagel | 1 |
22 | hyperventilating | 2 |
23 | individuals.as | 1 |
24 | intra-appointment | 1 |
25 | isorhamnetin- | 1 |
26 | jinfukang | 2 |
27 | management/pill | 1 |
28 | n-hydroxyl | 1 |
29 | nitrendipine-based | 1 |
30 | non-anesthetic | 1 |
31 | nonvasodilatory | 1 |
32 | o-formyl | 1 |
33 | omnii | 1 |
34 | other-type | 1 |
35 | outlicensing | 1 |
36 | peanuts/tree | 1 |
37 | pentamethylcyclopentadienyl | 1 |
38 | peptide-modified | 3 |
39 | polymerising | 2 |
40 | provided.single-chamber | 1 |
41 | raas-directed | 1 |
42 | rare.with | 1 |
43 | re-started | 3 |
44 | reported.zinc | 1 |
45 | requiringurinary | 1 |
46 | respondersto | 1 |
47 | self-titrated | 5 |
48 | service-connection | 1 |
49 | st/mi | 1 |
50 | standardized-one | 1 |
51 | sustained.when | 1 |
52 | taking | 8,722 |
53 | td49-encapsidated | 1 |
54 | university-student | 1 |
55 | very-high-dose | 2 |
56 | vigilance-stabilising | 1 |
1 | isorhamnetin- | 1 |
2 | 21/445 | 1 |
3 | giac | 1 |
4 | non-anesthetic | 1 |
5 | antidepressant/neuroleptic | 1 |
6 | reported.zinc | 1 |
7 | peptide-modified | 3 |
8 | nitrendipine-based | 1 |
9 | co-dispensed | 4 |
10 | higher-dosed | 1 |
11 | td49-encapsidated | 1 |
12 | self-titrated | 5 |
13 | elavated | 1 |
14 | raas-directed | 1 |
15 | re-started | 3 |
16 | argulid | 1 |
17 | peanuts/tree | 1 |
18 | fast-the | 1 |
19 | standardized-one | 1 |
20 | other-type | 1 |
21 | very-high-dose | 2 |
22 | accept/tolerate | 1 |
23 | 0.07g/kg | 1 |
24 | jinfukang | 2 |
25 | taking | 8,722 |
26 | 'taking | 7 |
27 | -taking | 2 |
28 | factor-lowering | 1 |
29 | centralising | 1 |
30 | vigilance-stabilising | 1 |
31 | polymerising | 2 |
32 | outlicensing | 1 |
33 | hyperventilating | 2 |
34 | delving | 1 |
35 | rare.with | 1 |
36 | omnii | 1 |
37 | st/mi | 1 |
38 | hufnagel | 1 |
39 | management/pill | 1 |
40 | o-formyl | 1 |
41 | pentamethylcyclopentadienyl | 1 |
42 | n-hydroxyl | 1 |
43 | 39m | 1 |
44 | sustained.when | 1 |
45 | service-connection | 1 |
46 | respondersto | 1 |
47 | dental/alveolar | 1 |
48 | provided.single-chamber | 1 |
49 | adherence-as | 1 |
50 | individuals.as | 1 |
51 | 6-dependent | 4 |
52 | 7-dependent | 5 |
53 | university-student | 1 |
54 | intra-appointment | 1 |
55 | requiringurinary | 1 |
56 | nonvasodilatory | 1 |